Llwytho...
IL-2 administration increases CD4(+)CD25(hi) Foxp3(+) regulatory T cells in cancer patients
Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4(+)CD25(+) regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been st...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
The American Society of Hematology
2006
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1473973/ https://ncbi.nlm.nih.gov/pubmed/16304057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-06-2399 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|